Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wiemer

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 4, 2016
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatmentJacqueline S L Kloth, Paul Hamberg, Pauline A J Mendelaar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2022
Major Vault Protein Prevents Atherosclerotic Plaque Destabilization by Suppressing Macrophage ASK1-JNK SignalingQingling Liu, Junlu Pan, Linrui Bao, et al.
Scientific Reports|July 10, 2019
Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wastingS Levolger, E A C Wiemer, J L A van Vugt, et al.
Frontiers in Oncology|November 16, 2020
Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A TumorsMilea J M Timbergen, Ruben Boers, Anne L M Vriends, et al.
The Oncologist|February 23, 2013
Evaluation of patient enrollment in oncology phase I clinical trialsDiane A J van der Biessen, Merlijn A Cranendonk, Gaia Schiavon, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2010
Effects of methimazole on the elimination of irinotecanJessica M van der Bol, Theo J Visser, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecanJessica M van der Bol, Ron H J Mathijssen, Geert-Jan M Creemers, et al.
BMJ Open|July 26, 2019
Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registryEvangelos Giannitsis, Piers Clifford, Anna Slagman, et al.
Molecular Cancer|November 19, 2015
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwayMarijn T M van Jaarsveld, Patricia F van Kuijk, Antonius W M Boersma, et al.
BMC Cancer|June 15, 2014
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3αCaroline M M Gits, Patricia F van Kuijk, Jonneke C W M de Rijck, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|February 4, 2016
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatmentJacqueline S L Kloth, Paul Hamberg, Pauline A J Mendelaar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2022
Major Vault Protein Prevents Atherosclerotic Plaque Destabilization by Suppressing Macrophage ASK1-JNK SignalingQingling Liu, Junlu Pan, Linrui Bao, et al.
Scientific Reports|July 10, 2019
Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wastingS Levolger, E A C Wiemer, J L A van Vugt, et al.
Frontiers in Oncology|November 16, 2020
Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A TumorsMilea J M Timbergen, Ruben Boers, Anne L M Vriends, et al.
The Oncologist|February 23, 2013
Evaluation of patient enrollment in oncology phase I clinical trialsDiane A J van der Biessen, Merlijn A Cranendonk, Gaia Schiavon, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2010
Effects of methimazole on the elimination of irinotecanJessica M van der Bol, Theo J Visser, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecanJessica M van der Bol, Ron H J Mathijssen, Geert-Jan M Creemers, et al.
BMJ Open|July 26, 2019
Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registryEvangelos Giannitsis, Piers Clifford, Anna Slagman, et al.
Molecular Cancer|November 19, 2015
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwayMarijn T M van Jaarsveld, Patricia F van Kuijk, Antonius W M Boersma, et al.
BMC Cancer|June 15, 2014
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3αCaroline M M Gits, Patricia F van Kuijk, Jonneke C W M de Rijck, et al.
Pageof 13